Rare lephants

Screener

Mesoblast Limited

MESO ·Healthcare, Drug Manufacturers - General, Australia

Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation

EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding

Share-Based Metrics › Shares Outstanding

← 5Y 10Y MAX →

Shares Outstanding

Fiscal Year	Shares Outstanding
FY2020	583.9M
FY2021	648.7M
FY2022	650.5M
FY2023	814.2M
FY2024	1.14B

About Contact Terms Privacy